Objective: Endometriosis is linked to altered cell proliferation and stem cell markers c-kit/stem cell factor (SCF) in ectopic endometrium. Our aim was to investigate whether c-kit/SCF also plays a role in eutopic endometrium. Design: Eutopic endometrium obtained from 35 women with endometriosis and 25 fertile eumenorrheic women was analyzed for in situ expression of SCF/c-kit, Ki67, RAC-alpha serine/threonine-protein kinase (Akt), phosphorylated RAC-alpha serine/threonin-protein kinase (pAkt), Glycogen synthase kinase 3 beta (GSK3b), and phosphorylated glycogen synthase kinase 3 beta (pGSK3b), throughout the menstrual cycle. Results: Expression of Ki67 and SCF was higher in endometriosis than in control tissue (P < .05) and greater in secretory rather than proliferative (P < .01) endometrium in endometriosis. Expression of c-kit was also higher in endometriosis although similar in both phases. Expression of Akt and GSK3b was identical in all samples and cycle phases, whereas pAkt and pGSK3b, opposed to control tissue, remained overexpressed in the secretory phase in endometriosis. Conclusion: Unceasing cell proliferation in the secretory phase of eutopic endometriosis is linked to deregulation of c-kit/SCF-associated signaling pathways.
Introduction
Endometriosis is a gynecologic pathology characterized by inflammation and invasion of endometrial cells into other tissues. It represents a widespread condition with a relevant impact on women health. [1] [2] [3] The pathophysiology of the genesis and progression of the disease is unclear and poorly understood. Endometriosis arises from eutopic endometrial cells with increased proliferation and adhesion ability in response to abnormal steroidogenic function, angiogenic factors, cytokines, and others. 4 In fact it has been demonstrated that augmented cell viability in eutopic endometrium is a consequence of reduction in cell death by apoptosis and an increase in cell proliferation. 5 Epithelial cells in normal endometrium and ectopic endometrial tissue of endometriotic lesions express stem cell markers oct-4 and c-kit. 6, 7 c-Kit is a proto-oncogene that encodes for a tyrosine kinase receptor, 8, 9 its ligand is the stem cell factor (SCF). 10 Stem cell factor and its receptor have been detected in pregnant endometrium, placental tissues, and in throphoblasts, 11, 12 suggesting a role in growth, proliferation, and differentiation processes. [13] [14] [15] Stem cell factor has also been found in the peritoneal fluid of patients with endometriosis. 16 c-kit/SCF signal transduction pathway is regulated through Ras/Erk, Src-kinase, or Jak/Stat, [17] [18] [19] but interestingly in endometrioid and high-grade serous ovarian carcinomas, the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and GSK3b have also been clearly identified. 20, 21 Endometriosis is considered a precancerous lesion associated with ovarian cancer, 22, 23 but strangely the expression and regulation of c-kit/SCF in eutopic endometriosis have not been distinctly examined. Therefore, our aim was to evaluate SCF and c-kit expression and their possible association with the Akt/GSK3b pathway in human eutopic endometrium biopsies of women with endometriosis.
Materials and Methods

Patients and Tissue Collection
All tissue samples of this case-control study were obtained with the informed consent of the patients. The research ethics committee of the Hospital de la Mujer, Secretaría de Salud, Mexico, Federal District, Mexico (permit id: HMINV-2012-07) approved the study, which was conducted in accordance with international laws on procedures for human tissue handling of Helsinki declaration (1964) . The control group consisted of 25 women aged 19 to 40 years old with no endometriosis manifestations who had an endometrial biopsy due to abnormal uterine bleeding, endometrial dating, evaluation of uterine response to hormone therapy (evidence of ovulation), evaluation of long-term amenorrhea, and exclude pelvic diseases. Nevertheless, endometriosis could not be entirely ruled out because laparoscopic visualization of the pelvis was not undertaken in these women. The histopathology analysis of these biopsies confirmed that 13 were in the proliferative phase and 12 in the secretory phase. When in doubt for possible ''red lesions,'' the ''suspicious'' biopsy samples are routinely subjected to a PGP9.5 immunostain to detect nerve fibers; none of the control group biopsies were positive for this marker. Endometrial tissue specimens were obtained from 35 women, 30 of them were nonsmokers, who underwent laparoscopy for stage III and IV endometriosis classified according to the American Society for Reproductive Medicine. 24 The most frequent presenting symptoms were menorrhagia, pelvic pain, or both. Eighty-five percent of the patients underwent laparoscopic evaluation of the pelvis; the remaining patients underwent an ultrasound evaluation. Median age of patients was 37 (range 25-52) years old. The diagnosis was histologically confirmed, but we did not find a relation between the Altman Self-Rating Mania Scale score and the patient's age. The surgical procedures were carried out by an expert gynecological surgeon in the Department of Obstetrics and Gynecology of the Hospital de la Mujer, Mexico City, Mexico, from January 2011 through October 2012. None of the women had received hormonal medication in the 3 months prior to the surgical procedure, and because of the most recent evidence, 25 their estrogen and progesterone serum concentrations that are regularly determined by the hospital's routine laboratory were within normal values. Menstrual cycle dating was determined by the clinical history and by histological description according to Noyes criteria. 26 Patients and control healthy women were considered to be Mexican Mestizo, and their body mass index of patients and control women was within the 20 to 31 kg/m 2 units range.
Immunohistochemistry
Endometrial biopsies were fixed in neutral-buffered 4% r-formaldehyde at 4 C overnight and were subsequently paraffin embedded. Before performing immunohistochemistry, sections of the tissues were stained with hematoxylin-eosin to corroborate the clinical diagnosis. Serial sections, 4-mm thick, were used for immunohistochemistry. Paraffin-embedded sections were dewaxed and rehydrated in decreasing concentrations of ethanol. Antigen retrieval was achieved by boiling the samples in 0.01 mol/L citrate of sodium (pH 6) for 20 to 40 minutes. The quenching of endogenous peroxidase was achieved by incubation with 0.3% hydrogen peroxide in methanol for 30 minutes at room temperature. After washing with phosphate-buffered saline (PBS), the slides were incubated with 2% albumin solution for 2 hours at room temperature and extensively washed with PBS. The slides were incubated at 4 C in a humid chamber overnight with primary antibody diluted in Tris-buffered saline containing 1% bovine serum albumin. Mouse monoclonal antihuman SCF (Santa Cruz Biotechnology, Santa Cruz Biotechnology, Inc., Dallas, Texas) diluted 1:200, mouse monoclonal anti-Ki67 (Biocare Medical, Biocare Medical, Concord, California) diluted 1:100, and a rabbit monoclonal anti-c-kit/CD117 (Biocare Medical, Biocare Medical, Concord, California) diluted 1:50 were used. At the end of the incubation period, the samples were extensively washed in PBS and labeled with an avidin-biotin peroxidase detection system for 2 hours (1:200; VECTASTAIN ABC Elite kit; Vector Laboratories, Inc, Burlington, Vermont) at room temperature. After extensive washing, 3,3 0 -diaminobenzidine (Vector Laboratories, Inc, Burlingame, California) was used as a chromogen. The samples were counterstained with hematoxylin and evaluated with a Nikon Eclipse E600 microscope (Nikon Instruments Inc., Melville, New York). Photographs from 5 different fields per slide were taken randomly. The number and percentage of immunopositive Ki67, SCF, and c-kit positive cells were quantified by image analysis using the NIH Image J software (developed at the U.S. National Institutes of Health, USA superseded by Image J and available on the internet at http://rsb.info.nih.gov/nih-image/) that transforms the image into an 8-bit image; the program then calculates the intensity of the stained area measuring the amount of pixels/square inch and converts the readings into a white to black numerical value, expressed as optical density (OD). The results so expressed were used for analysis purposes, as described previously. 27 
Immunofluorescence
Tissue sections prepared identically to that described previously, with the exception of the peroxidase blockage, were incubated at 4 C in a humid chamber overnight with primary antibody diluted in PBS. Rabbit polyclonal, anti-Akt1/2/3 (sc-8312, 1:100), anti-p-Akt1/2/3 (sc-7985-R, 1:100), antiGSK3b (sc-9166, 1:100), and anti-p-GSK3b (sc-11757-R, 1:100), all from Santa Cruz Biotechnology, were used. At the end of the incubation period, the samples were washed thrice in PBS followed by 2 hours incubation with a 1:200 dilution of the specific goat antirabbit immunoglobulin G-rhodamineconjugated antibody (Merck Millipore). The samples were counterstained with Hoechst 33342 benzimide (Life Technologies, Thermo Fisher Scientific, Waltham, Massachusetts) according to the manufacturer's instruction. Stained slides were stored at 4 C before being evaluated with a Nikon Eclipse E600 fluorescence microscope. Similar to the evaluation performed for the immunohistochemistry analysis, and also in 5 different fields per slide, but using the RBG stack instead of the 8 bits, the intensity of immunopositive cells was evaluated using the Image J software.
Statistical Analysis
Data were examined to determine their normal distribution using the DÁ gostino-Pearson normality test included in the software that we use. Once corroborated, the data were analyzed by an analysis of variance test, followed by a post hoc test using the Bonferroni comparisons. All the statistical analysis was performed with GraphPad Prism 5.0 software (San Diego, California). All values are expressed as the mean + standard deviation. Differences were considered statistically significant when P < .05.
Results
In the proliferative phase of both, case and control samples, columnar surface epithelium, long curving glands, uniform and small stroma cells with round nuclei, and numerous mitotic cells both in the glandular epithelium and stroma were observed. In the secretory phase, the columnar epithelium was cylindrical, the glands exhibited tortuosities and exhibited secretory vacuoles at the apical pole. The stroma showed edematous changes. Because of this, we considered that the eutopic endometrial morphology of control and endometriosis samples were similar in the proliferative as well as in the secretory phases ( Figure 1A-D) .
Expression of Ki67, SCF, and c-Kit Receptor
A significant increase in the number of Ki67 immunopositive nuclei was observed in the glandular epithelium during the proliferative phase of women with endometriosis. No histological differences were observed in stromal cells of endometriosis and control samples in the same phase (Figure 2A and B) . The mean percentage of Ki67 immunopositive cells in the endometriosis samples was 93.84% + 19% versus 62% + 94% in the control group (P < .01; Figure 2 ). Unexpectedly, a highly significant increase in the mean percentage of Ki67 immunopositive cells 62.14% + 8.27% versus 5.4% + 1.64% (P < .01) was observed in the glandular epithelium of endometriosis samples during the secretory phase ( Figure 2D ) in comparison with control samples ( Figure 2C) ; the difference was also observed in the stroma and it was also significant (25.14% + 6.76% vs 2.58% + 0.8%, P < .05; Figure 2) .
The expression of SCF in the glandular epithelium and stroma cells of endometriosis samples was also enhanced in the proliferative phase in comparison with control biopsies ( Figure  2E and F). The differences were highly significant (171.9 + 27.5 OD vs 62.19 + 7.91 OD, P < .01) for glandular epithelium; differences were also found in relation to stroma SCF expression (63.31 + 15.09 OD vs 7.25 + 2.09 OD; P < .05; Figure 2 ). It was interesting to observe that in the secretory phase of endometriosis biopsies, highly significant differences were also observed; the noticeable increase in the expression of SCF both in the glandular epithelium (120.6 + 23.17 OD vs 11.97 + 9.87 OD, P < .01) and in the stroma cells (64.82 + 19.43 OD vs 7.25 + 2.09 OD, P < .05; Figure 2G 
Expression of p-Akt and p-GSK3b
No significant differences in the expression of Akt and GSK3b were observed in the proliferative or the secretory phases of control and endometriosis biopsies. Nevertheless, there was a significantly increased expression of the phosphorylated Akt (S473) in the proliferative phase of endometriosis biopsies in comparison with the controls (P < .05); interestingly, this overexpression remained increased in the secretory phase of endometriosis biopsies, whereas, as expected, the control biopsies showed a nearly 50% reduction in pAkt expression; the differences were highly significant (Figure 3 ; P < .01). An identical behavior with the same statistical differences was observed when pGSK3b (S9) expression was evaluated (Figure 4) .
Discussion
Endometriosis is a chronic inflammatory disease characterized by increased cellular proliferation, adhesion, and invasion of tissue similar to uterine endometrium in the eutopic endometrium 28 and places other than those physiologically appropriate. Our results did not show evidence of histological differences between endometriosis eutopic endometrium and control biopsies. This suggests that in patients with endometriosis, the relative concentration of steroid hormones is not altered, but it does not rule out the firm concept that it is an estrogen-dependent pathology with progesterone resistance due to low progesterone-receptor levels. [29] [30] [31] In fact it appears that the regulation of the different subtypes of estrogen receptor and progesterone receptor isoforms mediates distinct responses to steroid hormones and differs between normal and eutopic endometria, 32 although the most recent evidence shows that the elevated endometrial concentrations of estrone and estradiol in endometriotic tissue are determined by local metabolism rather than circulating levels. 25 The proliferation of epithelial and stromal cells in endometriosis biopsies was increased in the proliferative phase, as determined by the cell cycle marker Ki67, but it was unexpectedly higher in the secretory phase of endometriosis biopsies. Our results are in accordance with those of Mourtzikou et al, 33 for control biopsies, but not as far as endometriosis is concerned. Expression of Ki67 is dependent on estrogens and is also linked to SCF/c-kit in other tissues and some cancers. 34, 35 Increased cell proliferation has been related to a reduction in cell death and an increase in cell proliferation due to abundance of c-myc, 5 although a differential regulation of micro-RNAs in the secretory and proliferative phase of the cycle, which is under hormonal control, 36 has also been considered. It has been suggested that different stem cell populations contribute to endometriosis pathogenesis. 37 Stem cell factor and its receptor c-kit regulate the differentiation, proliferation, and survival of stem/pluripotent cells in normal endometrium and play an important role in follicular development. 38 The expression of SCF increases in the proliferative phase and diminishes in the secretory phase 11 of normal endometrial phases. An interesting although relatively uncommon result was that some of the biopsies of the women with and without endometriosis showed occasional c-kitþ cells in the stroma, which seem to belong to some kind of undifferentiated mesenchymal stromal cells that require c-kit for maintenance. 39 This cells are possibly those considered as human endometrial side population cells that correspond to somatic stem cells and express c-kit 40 ; they can be found in stromal or epithelial endometrial compartments, but these clonogenic epithelial cells are weakly supported by SCF, especially those found in the stroma. 41 We could not establish a relation between the number of these putative stem cells and the (5) and the secretory phases (6) . An isotype match IgG stain was used as negative control for each of the antibodies used, and the result is shown in the inset in the low left side of the (C), (G), and (K) images. The S and GE within each figure mark the stroma and the glandular epithelium. Magnification Â400, scale bar ¼ 100 mm. The histograms in the right side of the images represent the mean + standard deviation of the values obtained for the endometrial biopsy samples of all the endometriosis (n ¼ 35) and the control (n ¼ 25) groups for each immunostain in the proliferative or the secretory phases. *P < .05 and **P < .01. CE indicates control epithelium; EE, endometriosis epithelium; CS, control stroma; ES, endometriosis stroma; IgG, immunoglobulin G.
degree of endometriosis; but nevertheless, it is possible that these cells that regulate the effect of growth factors on proliferation and differentiation of endometrial cells 39 have a central role in endometriosis. Schwab et al 42 have shown that clonogenicity does not vary from the proliferative to the secretory stage of the menstrual cycle or between active cycling and inactive endometrium for both epithelial and stromal cells. Thus, suggesting a complex regulation of these putative stem cells in the endometrium 42 possible dependent on local production of hormones and growth factors.
Our results showed that SCF expression was significantly increased in the glandular epithelium and stromal cells, whereas its c-kit receptor was only increased in the glandular epithelium, both in the proliferative and the secretory phases of women with endometriosis. Temporal changes in SCF and c-kit receptor expression during the normal menstrual cycle 11 and in benign endometrial tissues 43 have been reported, suggesting their possible involvement in endometrial function. Nevertheless, c-kit expression is controversial since its expression in the endometrium of women with endometriosis does not seem to differ from women without endometriosis. 44 Our results showed an important increase in pAkt and pGSK3b expression in the glandular epithelium during the proliferative and secretory phases of endometriosis. The SCF/c-kit interaction is involved in many cellular functions such as survival, proliferation, and apoptosis through the PI3K/Akt pathway 45 and GSK3b, a key regulatory kinase that participates in numerous signaling pathways. This signaling pathway participates in epithelial proliferation in uterine endometrium. 46, 47 Akt increases endometrial cell survival, and bestradiol-induced Akt phosphorylation of stromal cells may be involved in altered apoptosis/proliferation regulation in endometriosis. 48 This suggests that SCF/c-kit could promote epithelial cell proliferation and survival through Akt/GSK3b signaling, not only in the proliferative but also in the secretory phase of endometriosis. GSK3b is constitutively active, and its activity is negatively regulated primarily through Ser9 phosphorylation 49, 50 followed by Tyr216 phosphorylation both of which are mediated by Akt. 51 We showed that Akt and GSK3b remained phosphorylated during the secretory phase in endometriosis biopsies. Phosphorylation of Akt upregulates the expression of cell survival genes and downregulates apoptosis. 52 Our results confirm the observations made by Silveira et al 53 but might be considered puzzling since progesterone inhibits the AKT/GSK3b pathway related to epithelial proliferation 54 but GSK3b maintains progesterone receptor A stability. 55 Our results reinforce the importance of the PI3K/Akt pathway in endometriosis but contrary to the results of Cinar et al, 48 we showed that the sustained pAkt expression in both phases of the cycle, especially in the secretory phase, is nonestradiol dependent, thus advocating Akt as a major participant in the pathogenesis of endometriosis. The overall results of our work indicate that there is an increased expression of SCF/C-kit and an impaired signaling by the Figure 4 . Expression of GSK3b and pGSK3b (S9) in control and eutopic endometriosis endometrium. Representative images of GSK3b and pGSK3b (S9) expression in the proliferative phase of control endometrium (A and F), and eutopic endometriosis (B and G) endometrium. C and H, GSK3b and pGSK3b (S9) expression during the secretory phase in the control endometrium and (D and I) in eutopic endometrium with endometriosis. Arrows show GSK3b and pGSK3b (S9) localization. E and J, An isotype match immunoglobulin G stain used as negative control for each of the antibodies. Magnification Â1000, scale bar ¼ 10 mm. The histograms represent the mean + standard deviation of all the values obtained for the endometrial biopsy samples of the endometriosis (n ¼ 35) and the control (n ¼ 25) groups for each immunostain in the proliferative or the secretory phases. *P < .05. GE indicates glandular epithelium; S, stroma.
perpetuation of Akt and GSK3b phosphorylation in eutopic endometriosis that might maintain epithelial cell proliferation in the secretory phase of the menstrual cycle. We acknowledge that our results are solely based on immunohistochemistry stain data and although functional experiments, such as the therapeutic inhibition of Akt, 56 would be welcomed, so far they are not being considered in endometriosis.
